ストックスクリーナーアプリを入手
4.94
9.29%
0.42
アフターアワーズ：
5.00
0.06
+1.21%
Annexon Inc (ANNX) 最新ニュース
Annexon (ANNX) director William Waddill receives 65,000 stock options grant - Stock Titan
Annexon (NASDAQ: ANNX) director receives 65,000-share stock option grant - Stock Titan
[Form 4] Annexon, Inc. Insider Trading Activity - Stock Titan
Annexon (ANNX) director Bettina Cockroft awarded 65,000 stock options at $4.70 - Stock Titan
Annexon (ANNX) grants director Jung Choi 65,000 stock options at $4.70 - Stock Titan
Annexon (ANNX) director William Carson receives 65,000 stock options at $4.70 - Stock Titan
Annexon (NASDAQ: ANNX) EVP exercises stock options, lifts stake to 184,807 shares - Stock Titan
ANNX Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionEarnings Sentiment Score - newsline.com
Annexon Inc. (ANNX) Holds Steady Near Support as Biotech Sector Faces HeadwindsRisk Parity Rebalance - newsline.com
ANNX News | ANNEXON INC (NASDAQ:ANNX) - ChartMill
Annexon Stockholders Approve Directors, Compensation and Share Increase - TipRanks
Annexon (NASDAQ: ANNX) reports 2026 annual meeting vote outcomes - Stock Titan
Annexon Inc. (ANNX) Gains 2.13% as Biotech Stock Holds Above Key SupportCounter Trend Trade - newsline.com
ANNX: All proposals passed as late-stage therapies advance and cash runway extends into 2027 - TradingView
Annexon Inc Annual Shareholders Meeting Transcript - GuruFocus
Annexon eyes 'win season' with Q4 vision trial data, GBS filings ahead - MSN
Annexon maps 3 big pipeline catalysts ahead of Q4 vision-drug readout - MSN
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead - MarketBeat
Annexon Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
ANNX Stock Price, Quote & Chart - ChartMill
Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout - sharewise.com
ANNX: Three major clinical data readouts expected in 2024, each with strong differentiation - TradingView
Annexon Inc. (ANNX) Holds Steady Near Support as Consolidation ContinuesOversold Bounce Ideas - newsline.com
ANNX Q1 2026 Earnings: EPS Beat Guidance as Clinical Progress ContinuesSubscription Growth Report - The Legal Advocate
Annexon(ANNX.US) Director Buys US$3.32 Million in Common Stock - Moomoo
Annexon Inc. (ANNX) Shows Modest Gain: Biotech Stock Tests Key LevelsWide Range Bar - The Legal Advocate
Insider Purchase: Director at $ANNX Buys 613,497 Shares - Moomoo
Annexon director Muneer Satter buys $3.3m in common stock By Investing.com - Investing.com South Africa
Annexon director Muneer Satter buys $3.3m in common stock - Investing.com
Director-linked fund buys 613K Annexon (ANNX) shares in open market - Stock Titan
ANNX Q1 2026 Earnings: EPS Beat Driven by Cost Control Amid Pre-Revenue StageCFO Commentary Report - The Legal Advocate
ANNX Q1 2026 Earnings: EPS Surpasses Estimates by 22% as Biotech Advances PipelineEarnings Preview - The Legal Advocate
Annexon Insider Bought Shares Worth $3,319,019, According to a Recent SEC Filing - Moomoo
ANNX Q1 2026 Earnings: EPS Beat Surprise as Clinical-Stage Biotech Tightens Cost ControlPost-Earnings Drift - newsline.com
Annexon to Participate in Upcoming June Investor Conferences - Investing News Network
Annexon CEO Douglas Love to speak at Jefferies and Goldman Sachs in June - Stock Titan
ANNX Q1 2026 Earnings: EPS Beat Lifts Shares as Pre-Revenue Biotech AdvancesEarnings Revision Report - newsline.com
ANNX Q1 2026 Earnings: Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech HeadwindsGuidance Accuracy Score - newsline.com
Annexon Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Redmile Group, LLC's Annexon Inc(ANNX) Holding History - GuruFocus
Annexon Reports Inducement Grants to New Employees under Nasdaq Listing Rule 5635(4) - marketscreener.com
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Is Annexon (NASDAQ:ANNX) In A Good Position To Deliver On Growth Plans? - Moomoo
Annexon (ANNX) insiders/affiliates report 8.7M-share stake (5.4%) - Stock Titan
What Annexon (ANNX)'s -2.61% Decline Means for Investors 2026-05-15Pullback Trade - newsline.com
Wall Street analysts see a 165.52% upside in Annexon (ANNX): Can the stock really move this high? - MSN
Annexon, Inc.common stock (NQ: ANNX - FinancialContent
Annexon Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference - sharewise.com
Director William Carson Acquires Additional Shares of Annexon In - GuruFocus
Director adds Annexon (ANNX) shares in Rule 10b5-1 plan purchase - Stock Titan
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):